TScan Therapeutics (TCRX) Operating Income Growth (5y) (2025 - 2026)

TScan Therapeutics (TCRX) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,801.52 Bn	66,801.23 Bn	-
2	Nanobiotix	1,916.61 Bn	1,916.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.65 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.94 Bn	114.69 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.85 Bn	61.09 Bn	3.31 Bn
7	Belite Bio	63.06 Bn	63.06 Bn	-
8	Argenx Se	55.74 Bn	50.56 Bn	1.41 Bn
9	Revolution Medicines	37.48 Bn	37.48 Bn	-
10	TScan Therapeutics	100.19 Mn	-27.87 Mn	-

Download Data